ProGnosis Biotech is an innovative biotechnology company, specialized in developing and manufacturing next-generation immunoassays for food & feed safety and clinical diagnostics. Based in Larissa, Greece, and having also offices in Spain, Serbia and China, ProGnosis Biotech is an export-oriented enterprise which, through a large distribution network, exports ELISA kits and Lateral-flow tests to more than 40 countries worldwide. In order to consistently provide top-quality products, our company participates on a monthly basis in Proficiency Tests in the UK, France, Germany, Italy, and the US. Additionally, ProGnosis Biotech offers validated products from highly esteemed organizations worldwide. ProGnosis Biotech is certified with ISO 9001:2015 for all the R&D and production procedures as well as with ISO 13485:2016 for the development and manufacturing of in vitro diagnostic medical devices. Our mission is to provide innovative, accurate, and simple solutions to the challenges presented in the food safety & clinical diagnostics industries. "Accuracy through Innovation"